Harmonizing marketing approval of generic drugs in Europe: Regulatory agencies in Europe are working to harmonize the marketing approval pathway of generic medicines

被引：0

作者：

Milmo, Sean ^{[1
]}

机构：

[1] Essex, United Kingdom

来源：

Pharmaceutical Technology | 2014年 / 38卷 / 10期

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：22 / 24

共 21 条

[11] Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United States
Salcher-Konrad, Maximilian
Naci, Huseyin
Davis, Courtney
MILBANK QUARTERLY, 2020, 98 (04): : 1219 - 1256
[12] Comparison of regulatory approval system for medicines in emergency among Japan, the United States, the United Kingdom, Europe, and China
Edo, Kazuki
Kawano, Masahide
Maeda, Hideki
PLOS ONE, 2024, 19 (09):
[13] Generic Drugs Face Regulatory and Scientific Challenges FDA funds research to further development of innovative generics, while working to address review and approval issues
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2013, 26 (08) : 10 - 11
[14] How Generic Drugs are Registered in Europe, United Kingdom, Australia and New Zealand? - A Drug Regulatory Perspective
Sandeep, D. S.
Lavanya, Y. K.
Shailesh, T.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2023, 13 (03) : 440 - 445
[15] Impact Assessment of Divergence on Post-approval Changes Classifications of Latin America Region With Europe and the United States, and Propositions to Harmonize Classification Based on Risk as a Path to Build the Trust Between National Regulatory Agencies
Lucia, Maria Lucia De
Comesana, Christian
Rodriguez, Heraclio
Dangy-Caye, Agnes
CLINICAL THERAPEUTICS, 2024, 46 (02) : 164 - 172
[16] Challenges in regulatory marketing approval of drugs for the treatment of advanced non-small cell lung cancer based on non-inferiority trials
Sridhara, Rajeshwari
Malik, Shakuntala
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S540 - S540
[17] Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway
Shahzad, Mahnum
Naci, Huseyin
Esselen, Katharine M.
Dottino, Joseph A.
Wagner, Anita K.
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2024, 17 (01)
[18] Europe strives for a more efficient generic-drug approval framework: Proposals to make the decentralized procedure more efficient were discussed at the january 2015 ega conference
Milmo, Sean
Pharmaceutical Technology, 2015, 39 (03) : 20 - 22
[19] Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures
G Apolone
R Joppi
V Bertele'
S Garattini
British Journal of Cancer, 2005, 93 : 504 - 509
[20] Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures
Apolone, G
Joppi, R
Bertele, V
Garattini, S
BRITISH JOURNAL OF CANCER, 2005, 93 (05) : 504 - 509

← 1 2 3 →